1. Chiu, A. T., McCall, D. E., Price, W. A., Wong, P. C., Carini, D. J., Duncia, J. V., Wexler, R. R., Yoo, S. E., Johnson, A. L. and Timmermans, P. B. W. M., Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active anhihypertensive agent.J. Pharmacol. Exp. Ther., 252(2), 711–718 (1990).
2. Cody, R. J., Haemodynamic responses to specific renin-angiotensin inhibitors in hypertensive and congestive heart failure.Drugs, 28, 144–169 (1984).
3. Dyball, R. E. J., Potentiation of neurohypophyseal hormone release by urethane.J. Physiol. Lond., 245, 119 (1975).
4. Faber, J. E., Effects of althesin and urethan-chloralose on neurohumoral cardiovasscular regulation.Am. J. Physiol., 256, R757-R765 (1989).
5. Hof, R. P., Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem.Br. J. Pharmacol., 78, 375–394 (1983).